What is the current annual EBITDA of PEN?

As of today, PEN annual EBITDA is $206.72M

What is 1-year change in PEN annual EBITDA?

PEN annual EBITDA is up +82.19% year-over-year

What is 3-year change in PEN annual EBITDA?

PEN annual EBITDA is up +514.21% over the past 3 years

How far is PEN annual EBITDA from its all-time high?

PEN annual EBITDA is currently at its all-time high

How does PEN annual EBITDA rank versus sector peers?

PEN annual EBITDA is higher than 86.60% of companies in Healthcare sector

When is PEN next annual earnings release?

As of today, the next annual earnings release for PEN has not been scheduled

What is the current quarterly EBITDA of PEN?

As of today, PEN quarterly EBITDA is $46.65M

What is PEN quarterly EBITDA most recent change?

PEN quarterly EBITDA was up +8.98% on June 30, 2026

What is 1-year change in PEN quarterly EBITDA?

PEN quarterly EBITDA is up +0.69% year-over-year

How far is PEN quarterly EBITDA from its all-time high?

PEN quarterly EBITDA is currently -26.75% below its historical high of $63.69M set on December 31, 2025

How does PEN quarterly EBITDA rank versus sector peers?

PEN quarterly EBITDA is higher than 84.29% of companies in Healthcare sector

When is PEN next earnings release?

The next earnings release for PEN is on November 4, 2026

What is the current TTM EBITDA of PEN?

As of today, PEN TTM EBITDA is $204.48M

What is PEN TTM EBITDA most recent change?

PEN TTM EBITDA was up +0.16% on June 30, 2026

What is 1-year change in PEN TTM EBITDA?

PEN TTM EBITDA is up +12.41% year-over-year

How far is PEN TTM EBITDA from its all-time high?

PEN TTM EBITDA is currently -1.08% below its historical high of $206.72M set on December 31, 2025

How does PEN TTM EBITDA rank versus sector peers?

PEN TTM EBITDA is higher than 85.73% of companies in Healthcare sector

When is PEN next earnings release?

The next earnings release for PEN is on November 4, 2026

Penumbra, Inc. (PEN) EBITDA History & Chart Since 2012

Annual EBITDA

$206.72M$93.26M+82.19%

December 31, 2025

Summary

Current Value: As of today, PEN annual EBITDA is $206.72M, up +82.19% on December 31, 2025
Historical Performance: PEN annual EBITDA is up +514.21% over the past 3 years, up +1095.57% over the past 5 years
All-Time High Comparison: PEN annual EBITDA is currently at its all-time high
3-Year Low Comparison: PEN annual EBITDA is +514.21% above its 3-year low of $33.66M reached on an earlier date
Sector Comparison: PEN annual EBITDA is higher than 86.60% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

PEN Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$206.72M	+82.2%	+514.2%	+1095.6%	+5930.3%
Quarterly EBITDA	Jun 30, 26	$46.65M	+0.7%	+89.7%	+236.5%	+2230.4%
TTM EBITDA	Jun 30, 26	$204.48M	+12.4%	+229.2%	+1202.8%	+10000.0%
Price	Aug 14, 26	$327.02	+29.1%	+27.9%	+26.9%	–
PE Ratio	Aug 14, 26	80.31	+19.6%	-76.7%	-87.1%	–
Annual Revenue	Dec 31, 25	$1.40B	+17.5%	+65.7%	+150.5%	+1819.1%
Annual EPS	Dec 31, 25	$4.52	+1167.4%	+8648.6%	+1130.1%	+5559.8%
	Dec 31, 25	$189.25M	+119.5%	+3011.6%	+619.3%	+5420.7%
Annual Net Income	Dec 31, 25	$177.69M	+1168.1%	+8975.5%	+1022.7%	+8974.9%

EBITDA Highs

PEN Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$206.72M	Dec 31, 25	at high
5Y	$206.72M	Dec 31, 25	at high
All	$206.72M	Dec 31, 25	at high

EBITDA Lows

PEN Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$33.66M	N/A	+514.2%
5Y	-$20.76M	N/A	+1095.6%
All	-$20.76M	Dec 31, 20	+1095.6%

EBITDA History

Year	Value	Change
2025	$206.72M	+82.2%
2024	$113.47M	-7.3%
2023	$122.37M	+263.6%
2022	$33.66M	+180.7%
2021	$11.99M	+157.7%
2020	-$20.76M	-137.5%
2019	$55.33M	+49.1%

Year	Value	Change
2018	$37.10M	+650.1%
2017	$4.95M	+422.3%
2016	$947.00K	-84.0%
2015	$5.93M	+57.7%
2014	$3.76M	+937.4%
2013	-$449.00K	-113.1%
2012	$3.43M	-

FAQ

What is the current annual EBITDA of PEN?: As of today, PEN annual EBITDA is $206.72M
What is 1-year change in PEN annual EBITDA?: PEN annual EBITDA is up +82.19% year-over-year
What is 3-year change in PEN annual EBITDA?: PEN annual EBITDA is up +514.21% over the past 3 years
How far is PEN annual EBITDA from its all-time high?: PEN annual EBITDA is currently at its all-time high
How does PEN annual EBITDA rank versus sector peers?: PEN annual EBITDA is higher than 86.60% of companies in Healthcare sector
When is PEN next annual earnings release?: As of today, the next annual earnings release for PEN has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$46.65M$3.85M+8.98%

June 30, 2026

Summary

Current Value: As of today, PEN quarterly EBITDA is $46.65M, up +8.98% on June 30, 2026
Historical Performance: PEN quarterly EBITDA is up +0.69% year-over-year, up +89.66% over the past 3 years
All-Time High Comparison: PEN quarterly EBITDA is currently -26.75% below its historical high of $63.69M set on December 31, 2025
3-Year Low Comparison: PEN quarterly EBITDA is +1184.88% above its 3-year low of $3.63M reached on June 30, 2024
Sector Comparison: PEN quarterly EBITDA is higher than 84.29% of companies in Healthcare sector

Performance

PEN Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Jun 30, 26	$46.65M	+9.0%	+0.7%	+89.7%	+236.5%
Annual EBITDA	Dec 31, 25	$206.72M	–	+82.2%	+514.2%	+1095.6%
TTM EBITDA	Jun 30, 26	$204.48M	+0.2%	+12.4%	+229.2%	+1202.8%
Price	Aug 14, 26	$327.02	+1.3%	+29.1%	+27.9%	+26.9%
PE Ratio	Aug 14, 26	80.31	+8.1%	+19.6%	-76.7%	-87.1%
Quarterly Revenue	Jun 30, 26	$390.05M	+4.1%	+14.9%	+49.2%	+111.7%
Quarterly EPS	Jun 30, 26	$0.88	+6.8%	-23.7%	+81.9%	+258.2%
	Jun 30, 26	$41.04M	+7.3%	+0.5%	+129.4%	+298.0%
Quarterly Net Income	Jun 30, 26	$34.81M	+6.8%	-23.1%	+83.6%	+319.5%

Quarterly EBITDA Highs

PEN Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$63.69M	Dec 31, 25	-26.8%
3Y	$63.69M	Dec 31, 25	-26.8%
5Y	$63.69M	Dec 31, 25	-26.8%
All	$63.69M	Dec 31, 25	-26.8%

Quarterly EBITDA Lows

PEN Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$42.81M	Mar 31, 26	+9.0%
3Y	$3.63M	Jun 30, 24	+1184.9%
5Y	-$34.30M	Dec 31, 21	+236.0%
All	-$34.30M	Dec 31, 21	+236.0%

Quarterly EBITDA History

Month	Value	Change
Jun 2026	$46.65M	+9.0%
Mar 2026	$42.81M	-32.8%
Dec 2025	$63.69M	+24.1%
Sep 2025	$51.33M	+10.8%
Jun 2025	$46.33M	+2.1%
Mar 2025	$45.37M	-10.5%
Dec 2024	$50.70M	+28.3%
Sep 2024	$39.51M	+988.2%
Jun 2024	$3.63M	-81.5%
Mar 2024	$19.62M	-56.8%
Dec 2023	$45.42M	+20.2%
Sep 2023	$37.77M	+53.6%
Jun 2023	$24.60M	+68.7%
Mar 2023	$14.58M	+29.4%
Dec 2022	$11.27M	-3.3%
Sep 2022	$11.66M	+101.4%
Jun 2022	$5.79M	+244.6%
Mar 2022	$1.68M	+104.9%
Dec 2021	-$34.30M	-376.3%
Sep 2021	$12.41M	-10.5%
Jun 2021	$13.86M	-18.1%
Mar 2021	$16.93M	+888.6%
Dec 2020	$1.71M	+110.2%
Sep 2020	-$16.82M	-39.9%

Month	Value	Change
Jun 2020	-$12.02M	-436.7%
Mar 2020	$3.57M	-72.2%
Dec 2019	$12.83M	-14.7%
Sep 2019	$15.03M	+2.0%
Jun 2019	$14.73M	+13.7%
Mar 2019	$12.96M	+52.8%
Dec 2018	$8.48M	-26.9%
Sep 2018	$11.60M	+4.2%
Jun 2018	$11.13M	+90.5%
Mar 2018	$5.84M	+13.3%
Dec 2017	$5.16M	+180.1%
Sep 2017	$1.84M	+428.7%
Jun 2017	-$560.00K	+59.8%
Mar 2017	-$1.39M	-109.6%
Dec 2016	-$664.00K	+5.1%
Sep 2016	-$700.00K	-1,029.0%
Jun 2016	-$62.00K	-102.6%
Mar 2016	$2.37M	+1.2%
Dec 2015	$2.35M	-23.9%
Sep 2015	$3.08M	+190.5%
Jun 2015	-$3.41M	-178.7%
Mar 2015	$4.33M	+516.5%
Jun 2014	$702.00K	-64.9%
Mar 2014	$2.00M	-

FAQ

What is the current quarterly EBITDA of PEN?: As of today, PEN quarterly EBITDA is $46.65M
What is PEN quarterly EBITDA most recent change?: PEN quarterly EBITDA was up +8.98% on June 30, 2026
What is 1-year change in PEN quarterly EBITDA?: PEN quarterly EBITDA is up +0.69% year-over-year
How far is PEN quarterly EBITDA from its all-time high?: PEN quarterly EBITDA is currently -26.75% below its historical high of $63.69M set on December 31, 2025
How does PEN quarterly EBITDA rank versus sector peers?: PEN quarterly EBITDA is higher than 84.29% of companies in Healthcare sector
When is PEN next earnings release?: The next earnings release for PEN is on November 4, 2026

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$204.48M$320.00K+0.16%

June 30, 2026

Summary

Current Value: As of today, PEN TTM EBITDA is $204.48M, up +0.16% on June 30, 2026
Historical Performance: PEN TTM EBITDA is up +12.41% year-over-year, up +229.20% over the past 3 years
All-Time High Comparison: PEN TTM EBITDA is currently -1.08% below its historical high of $206.72M set on December 31, 2025
3-Year Low Comparison: PEN TTM EBITDA is +229.20% above its 3-year low of $62.12M reached on an earlier date
Sector Comparison: PEN TTM EBITDA is higher than 85.73% of companies in Healthcare sector

Performance

PEN Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Jun 30, 26	$204.48M	+0.2%	+12.4%	+229.2%	+1202.8%
Annual EBITDA	Dec 31, 25	$206.72M	–	+82.2%	+514.2%	+1095.6%
Quarterly EBITDA	Jun 30, 26	$46.65M	+9.0%	+0.7%	+89.7%	+236.5%
Price	Aug 14, 26	$327.02	+1.3%	+29.1%	+27.9%	+26.9%
PE Ratio	Aug 14, 26	80.31	+8.1%	+19.6%	-76.7%	-87.1%
TTM Revenue	Jun 30, 26	$1.50B	+3.5%	+17.6%	+60.5%	+124.1%
TTM EPS	Jun 30, 26	$4.07	-6.3%	+8.0%	+448.4%	+881.7%
	Jun 30, 26	$187.34M	+0.1%	+17.6%	+418.0%	+9907.7%
TTM Net Income	Jun 30, 26	$160.59M	-6.1%	+8.7%	+451.3%	+1240.4%

TTM EBITDA Highs

PEN TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$206.72M	Dec 31, 25	-1.1%
3Y	$206.72M	Dec 31, 25	-1.1%
5Y	$206.72M	Dec 31, 25	-1.1%
All	$206.72M	Dec 31, 25	-1.1%

TTM EBITDA Lows

PEN TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$181.91M	N/A	+12.4%
3Y	$62.12M	N/A	+229.2%
5Y	-$15.18M	Sep 30, 22	+1447.5%
All	-$23.55M	Dec 31, 20	+968.3%

TTM EBITDA History

Month	Value	Change
Jun 2026	$204.48M	+0.2%
Mar 2026	$204.16M	-1.2%
Dec 2025	$206.72M	+6.7%
Sep 2025	$193.73M	+6.5%
Jun 2025	$181.91M	+30.7%
Mar 2025	$139.21M	+22.7%
Dec 2024	$113.47M	+4.9%
Sep 2024	$108.18M	+1.6%
Jun 2024	$106.44M	-16.5%
Mar 2024	$127.41M	+4.1%
Dec 2023	$122.37M	+38.7%
Sep 2023	$88.23M	+42.0%
Jun 2023	$62.12M	+43.4%
Mar 2023	$43.31M	+42.4%
Dec 2022	$30.40M	+300.3%
Sep 2022	-$15.18M	-5.2%
Jun 2022	-$14.42M	-127.2%
Mar 2022	-$6.35M	-171.3%
Dec 2021	$8.91M	-80.2%
Sep 2021	$44.92M	+186.2%
Jun 2021	$15.70M	+254.1%
Mar 2021	-$10.19M	+56.7%
Dec 2020	-$23.55M	-89.4%
Sep 2020	-$12.44M	-164.1%

Month	Value	Change
Jun 2020	$19.41M	-58.0%
Mar 2020	$46.16M	-16.9%
Dec 2019	$55.55M	+8.5%
Sep 2019	$51.20M	+7.2%
Jun 2019	$47.76M	+8.2%
Mar 2019	$44.16M	+19.2%
Dec 2018	$37.05M	+9.8%
Sep 2018	$33.73M	+40.7%
Jun 2018	$23.97M	+95.2%
Mar 2018	$12.28M	+143.4%
Dec 2017	$5.05M	+751.1%
Sep 2017	-$775.00K	+76.6%
Jun 2017	-$3.32M	-17.7%
Mar 2017	-$2.82M	-397.6%
Dec 2016	$947.00K	-76.1%
Sep 2016	$3.96M	-48.9%
Jun 2016	$7.74M	+76.1%
Mar 2016	$4.39M	-30.8%
Dec 2015	$6.35M	+58.6%
Sep 2015	$4.00M	+334.2%
Jun 2015	$922.00K	-81.7%
Mar 2015	$5.03M	+86.0%
Jun 2014	$2.70M	+35.1%
Mar 2014	$2.00M	-

FAQ

What is the current TTM EBITDA of PEN?: As of today, PEN TTM EBITDA is $204.48M
What is PEN TTM EBITDA most recent change?: PEN TTM EBITDA was up +0.16% on June 30, 2026
What is 1-year change in PEN TTM EBITDA?: PEN TTM EBITDA is up +12.41% year-over-year
How far is PEN TTM EBITDA from its all-time high?: PEN TTM EBITDA is currently -1.08% below its historical high of $206.72M set on December 31, 2025
How does PEN TTM EBITDA rank versus sector peers?: PEN TTM EBITDA is higher than 85.73% of companies in Healthcare sector
When is PEN next earnings release?: The next earnings release for PEN is on November 4, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

PEN Official Website www.penumbrainc.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1321732/000132173226000007/0001321732-26-000007-index.htm
PEN Profile on Yahoo Finance finance.yahoo.com/quote/PEN
PEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pen